APA (7th ed.) Citation

Xiuqing Zhu, Xiuqing Zhu, Yuexin Li, Huan Luo, Yunxia Zhang, Zhenqing Zhang, & Jinglai Li. (2024). In vitro, in vivo, and in silico approaches for evaluating the preclinical DMPK profiles of ammoxetine, a novel chiral serotonin and norepinephrine reuptake inhibitor. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Xiuqing Zhu, Xiuqing Zhu, Yuexin Li, Huan Luo, Yunxia Zhang, Zhenqing Zhang, and Jinglai Li. In Vitro, in Vivo, and in Silico Approaches for Evaluating the Preclinical DMPK Profiles of Ammoxetine, a Novel Chiral Serotonin and Norepinephrine Reuptake Inhibitor. Frontiers Media S.A., 2024.

MLA (9th ed.) Citation

Xiuqing Zhu, et al. In Vitro, in Vivo, and in Silico Approaches for Evaluating the Preclinical DMPK Profiles of Ammoxetine, a Novel Chiral Serotonin and Norepinephrine Reuptake Inhibitor. Frontiers Media S.A., 2024.